Cognitive decline in Parkinson’s disease: the complex picture

@inproceedings{Biundo2016CognitiveDI,
  title={Cognitive decline in Parkinson’s disease: the complex picture},
  author={Roberta Biundo and Luca Weis and Angelo Antonini},
  booktitle={npj Parkinson's Disease},
  year={2016}
}
Mild cognitive impairment (PD-MCI) and dementia (PDD) are among the most frequent non-motor symptoms in Parkinson’s disease (PD). PD-MCI is six times more likely than age-matched controls to develop dementia and the PDD prevalence is 80% after 15–20 years of disease. Therefore, research has focused on the identification of early dementia biomarkers including specific cognitive at-risk profiles hoping to implement therapeutic interventions when they are most likely to be efficacious. However… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 22 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 90 REFERENCES

Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review.

  • Movement disorders : official journal of the Movement Disorder Society
  • 2015
VIEW 8 EXCERPTS
HIGHLY INFLUENTIAL

Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease.

  • Movement disorders : official journal of the Movement Disorder Society
  • 2012
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

I Litvan
  • Mov. Disord
  • 2012
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL